CL-900i/CL-960i

CLIA technology permits analytical procedures with lower analyte detection limits than other immunoassay methods. In other words, CLIA is able to determine the presence of antibodies at extremely low concentrations. Mindray is having a wide range of CLIA analyzers.

The company had recently launched CL-900i/CL-960i one of the world’s smallest, fully automated chemiluminescence immunoassay analyzers and integrates a large capacity and fast assay speed into a compact model. It achieves a perfect balance between size and immunoassay testing performance. With enhanced enzymatic chemiluminescence, patented technologies and Mindray quality heritage, the system guarantees the robust consistency with the higher end analyzer.

The system combines continuous-access, random-access, and STAT processing with a broad testing menu, allowing medium- and low-volume clinical laboratories to process a variety of immunodiagnostic tests simultaneously and to add tests while the instrument is running.

CL-900i is designed for both quantitative and qualitative in vitro assay determinations for a broad range of applications, the test menu includes tumor markers, cardiac markers, fertility panel, diabetes panel, anemia panel, bone metabolism parameters, and thyroid markers.

Other unique features include precise three phase magnetic separation with consistent performance, environmental friendly solid-liquid waste separation, wiper washing technology which enhances efficiency and minimizes the carryover, continuously loading of intelligent consumables management reagents and consumables, non-touch vortexer mixing.
With intelligent sample workflow and high system reliability, CL-900i/CL-960i is a robust and compact immunoassay analyzer, which highly suits for medium and low volume clinical laboratories.